, . , , - . , , .
19 2012 (Food and Chemical Toxicology)
(
) - « Roundup Roundup- ». , , -, , .
« : − ».
NK603, , , 5---- (EPSPS), , Roundup. R (, ) , . , . , .
1.
, . 200 , 100 . 10 . - (11, 22 33% ), R. , R . (10 10 ) . .
. , 25% ( 25% ), , . , , , , , 30 , .
«» . 600-650 , 680-720, 5 ( ), 3 ( ) − . , , , ( ), , , , , .
30% 20% , , « - 50% 70% » − .
– , – . -, R. - 11, 22 33% , , . , , , , R . ( ).2.
. 10 90 . - , , . . , .
, ,
, : « . 10 , , 30 , ( , ), 30 ( ) 30 , , . , , . «, – , – !» – - ».
, , – . , , -. , , .
- (Sprague Dawley) –
. , . 18
45% ( , ).
. .
, , . - 80% (
). – , - .
, («a threshold in effect was reached at the lowest doses»). . ,
- . 22 33% - -, R , 10%, .
, : « - , !». , , «- ».
(«The purpose of the addition of R treated groups was not to assess R long term carcinogenesis»), , . , . , . , , .
, , , -, .
Table 2. Summary of the most frequent anatomical pathologies observed.
, . , . - , , ( , ). (CPN), 11% 22% + R. , , ; . , . . 1.. -, , − . -, , . , , , − . . , .
, ,
«Food and Chemical Toxicology»:
«
- , . . , . , , , . .
. , , , , , . , , .
, 6 6 , ( ), , 6 6 ».
, , , , , , – .
, .
.
, «» , ? () . , («This 2 year life-long experiment was conducted in a GPL environment according to OECD guidelines»), «» :
50 , («...we have prolonged the biochemical and hematological measurements or disease status recommended in combined chronic studies using 10 rats per group (up to 12 months in OECD 453)).
, 10 − 90- - , . − , , − , , 20 , , , 50 .
, , Harlan Laboratories, , , Sprague-Dawley 104 . 90- , . , , , 50% 104 . , − 65 . (
Nature ).
3.
Monsanto Company, NK603.
(EFSA), , .
,
.
( , , , , , ) (
).
. EFSA, , (, , , , )
(157 ), .
, .
, . ,
, − « , ». . :
- (EFSA).
- (EFSA).
- , ( ).
- . , , , , . , « », , . ( EFSA).
- EFSA. , 90- («in order to know if the statistical findings (in 90 days), were biologically relevant or not on a long term»). , . , : , . ( ).
- : « . : , , » ( ).
- « ». . 12 ( ) 12 ( 5 ). - .
, , , , , , - ( , -), Monsanto Company NK603 .
: « , . , » (
Slon).
, ,
, .
4.
.
-, , , , , (
Nature). , . , , .
« ?», . 1999 (CRIIGEN) - .
-, . , «TOUS COBAYES?» (« ?») .
.
-, : «A refund of the cost of the study of several million euros would be considered damages if the premature disclosure questioned the release of the study». . .
, . , 22 - : «
: – ». , .
–
. , − , . , . .
.
«La vérité sur les OGM, c'est notre affaire!» (« – !») , e CRIIGEN.
L’EXPRESS
. Auchan. Carrefour, CRIIGEN. Carrefour « » (
).
, , .
, . 40 , .